Journal details
CURRENT MOLECULAR PHARMACOLOGY
KEAI PUBLISHING LTD · ISSN 1874-4672 · eISSN 1874-4702
SCIEScopusMEDLINEPubMedPMC
Overview
CURRENT MOLECULAR PHARMACOLOGY is a Biochemistry & Molecular Biology · Pharmacology & Pharmacy journal published by KEAI PUBLISHING LTD (Netherlands). Use this page to check its impact factor, JCR quartile, CAS zone and indexing before you submit. Always confirm the scope, APC and policies on the journal's official website.
Publication output
2026: 11 articles · 2025: 40 articles · 2024: 48 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of CURRENT MOLECULAR PHARMACOLOGY?
The impact factor recorded for CURRENT MOLECULAR PHARMACOLOGY is 7.2 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of CURRENT MOLECULAR PHARMACOLOGY?
CURRENT MOLECULAR PHARMACOLOGY is listed in CAS Zone 4.
Which databases index CURRENT MOLECULAR PHARMACOLOGY?
CURRENT MOLECULAR PHARMACOLOGY is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.